Leerink Partnrs Issues Optimistic Outlook for IRWD Earnings
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Investment analysts at Leerink Partnrs increased their Q2 2025 earnings per share (EPS) estimates for shares of Ironwood Pharmaceuticals in a report issued on Wednesday, May 7th. Leerink Partnrs analyst F. Khurshid now expects that the biotechnology company will post earnings per share of ($0.05) for the […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Investment analysts at Leerink Partnrs increased their Q2 2025 earnings per share (EPS) estimates for shares of Ironwood Pharmaceuticals in a report issued on Wednesday, May 7th. Leerink Partnrs analyst F. Khurshid now expects that the biotechnology company will post earnings per share of ($0.05) for the […]
